Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Plant Health Care Plc | PHC | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 8.925 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 8.925 |
| Industry Sector |
|---|
| CHEMICALS |
| Top Posts |
|---|
Posted at 02/8/2024 14:31 by 1pencil Cerrito by your own admission, why would you vote against something that is in your best financial interest ?US markets are in dire shape, PHC will likely need more cash to survive without the takeover. |
Posted at 02/6/2024 22:59 by pretax2 Thanks for your balanced comments Cerrito. There are always risks with small companies and PHC are no different; as you know.I agree, 25% is not a bad growth rate in normal times… however, with the destocking issue, growth went into reverse last year. So sub 25% growth this year building from a -5% baseline would not be so good, especially with so many new markets and products coming on stream for the company. It would suggest a very lukewarm reception for PHC products. I look at LinkedIn a lot (we all do) and the PHC field teams have worked tirelessly to promote the new product launches. There have been field trials, adverts, promotions as well as conference presentations. Early indications in 2024 are very positive. The company have growth milestones which they appear to take very seriously. That’s good, and in recent weeks I’ve started to rediscover my optimism. The shareprice recovery also suggests we’re striding forwards. All IMO. |
Posted at 31/5/2024 06:55 by pretax2 Final reporting date is actually the 28th June I believe. I get the feeling that the market for sustainable agrotech is getting rosier benefitting PHC. For example the EU are close to banning ‘forever’Farmers have to replace them with something - nudge - residue free peptides from PHC perhaps? As things improve I guess PHC will want to lace their 2023 FY reporting with positive forward statements. To be honest the 2023 FY lacks relevance today, given the temporary destocking blip is resolving. |
Posted at 21/5/2024 08:06 by fillipe A good start today at PHC.Looking forward to a further new geographical area of the world signing up for PHC product. f |
Posted at 13/5/2024 21:03 by cerrito I see, once again no surprise ,that trading activity on Thursday and Friday last week very active by PHC standards although not as active as Wednesday..but still active enough for people to exit. Activity today better than Friday.Perhaps people put off by comments on need for more working capital finance not surprising given the cash burn of us1.7m in the first 4 months(facturing in the receivables payment) in the context of cash at us2.3m at end April. I have been trying to figure out what is the main user of working capital.. At first glance you could say it is payables. At 12.21 and 12.22 trade payable were us1.3m and us1.6m way below inventories which were us2 1m and us 3.4m but the problem with that is that raw material inventories were low, there is no work in progress and the vast bulk are finished goods. Of course we are only told trade payables on one day a year and the business has moved on. Total receivables in H1 23 were just under 90 days but 101 days in H122 and about 55 days in H2 22. Difficult to get a steer as they move around so much. I am perplexed by the us1.5m receivable paid in January given that total receivables at June 30 were us2.5m. It would not have been from Wilbur Ellis and Nutrien who are far too big to mess around with a to them very small figure and presumably given that Saori sales are made mid year there would have been no receivables outstanding from Nutrien.I can only assume it is tied to Brazil sugar cane sales but even that figure seems v large. I hope that in the IMC we can go into the working capital cycle. |
Posted at 08/5/2024 17:19 by pretax2 This is just the start. Wait until they start selling in China (distribution deal in place), India and the EU; as well as N & S America. We're just getting going here.As CR says, he wants a "PHC product on every field". |
Posted at 08/5/2024 07:12 by kaos3 I did not like selective dates and data used at the beginning. 22,23,24 all aroundAnd LBITDA in 2023 improved 32% to $2.8m (2022: $3.5m), with further improvement expected during 2024. All that put some fog on my phc shares |
Posted at 16/4/2024 07:24 by cerrito From the way it is worded my reading is that no regulatory approvals are required in China but would have been good to get clarity on this.Confused by the reference to novel as it is good old harpin and my reading is that it is because it is being incorporated into an existing AMVAC product line. I may be wrong but if true could be v exciting. American Vanguard is listed and describes itself as an agriculture and speciality chemical company. Sales and profits declined in 2023 over 2022 and indeed eps declined from 92us cents to 26.It does have a green division.They attributed fall in 2023 sales to our old friend destocking(though said this reversed in q4 calendar 2023), oversupply of Chinese generic products(not a PHC issue) and supply chain problems. |
Posted at 16/4/2024 06:43 by pretax2 There’re no figures on this RNS, but China distribution commencing this year is a huge opportunity for PHC. I look forward to hearing more; also nice to know PHC are alive and kicking. |
Posted at 07/4/2024 17:44 by pretax2 Hi CerritoNot sure how to interpret this (+ve or -ve) as far as PHC is concerned. 1/ "Indigo expanded into too many product areas": PHC have not - they've stuck with Harpin derived peptides. 2/ "Industry of slow adapters": Accepted; but environmental (and supermarket) policy is forcing growers to embrace sustainable growing techniques or lose market share. 3/ "Many of these agtech companies are not ‘tech’ companies, they are simply ‘tech enabled’". ['Tech enabled'?] Harpin is a scientific discovery which has been adapted and enhanced by PHC at its Seattle laboritory. All of the IP belongs to PHC. Somewhat paradoxically, Covid was 'initially' a good thing for PHC (distributors over-stocked), but now a bad thing with the current destocking. This out to be ending around about now so we can get back on the growth path. Time for an update. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
